Jeffrey Busch
Insider
First SEC filing: March 9, 2021 · Latest: March 9, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2025 | XRN | A | 23,613 | · | · | 745,015 Direct | +3.27% | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2024 | XRN | A | 29,384 | · | · | 721,402 Direct | +4.25% | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2024 | XRN | A | 62,176 | · | · | 692,018 Direct | +9.87% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2023 | XRN | A | 13,175 | · | · | 629,842 Direct | +2.14% | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2023 | XRN | A | 36,563 | · | · | 616,667 Direct | +6.30% | Acquired | (price as of 2026-10-02) |
| March 4, 2022 | XRN | A | 27,698 | · | · | 580,104 Direct | +5.01% | Acquired | (price as of 2026-10-02) |
| March 3, 2022 | XRN | P | 2,000 | $15.55 | $31,100 | 43,490 Direct | +4.82% | Acquired | -56.3% (price as of 2026-10-02) |
| Feb. 28, 2022 | XRN | A | 18,116 | · | · | 552,406 Direct | +3.39% | Acquired | (price as of 2026-10-02) |
| Aug. 19, 2021 | XRN | P | 1,000 | $15.01 | $15,010 | 41,490 Direct | +2.47% | Acquired | -54.7% (price as of 2026-10-02) |
| May 26, 2021 | XRN | A | 8,890 | · | · | 519,432 Direct | +1.74% | Acquired | (price as of 2026-10-02) |
| March 8, 2021 | XRN | P | 750 | $13.81 | $10,358 | 39,490 Direct | +1.94% | Acquired | -50.7% (price as of 2026-10-02) |
| March 8, 2021 | XRN | P | 1,000 | $13.81 | $13,810 | 40,490 Direct | +2.53% | Acquired | -50.7% (price as of 2026-10-02) |
| March 2, 2021 | XRN | A | 39,680 | · | · | 510,542 Direct | +8.43% | Acquired | (price as of 2026-10-02) |
| March 2, 2021 | XRN | A | 34,759 | · | · | 470,862 Direct | +7.97% | Acquired | (price as of 2026-10-02) |
| Aug. 7, 2020 | XRN | P | 10,000 | $13.39 | $133,900 | 38,740 Direct | +34.79% | Acquired | -49.2% (price as of 2026-10-02) |
| July 9, 2020 | XRN | A | 191,205 | · | · | 436,103 Direct | +78.08% | Acquired | (price as of 2026-10-02) |
| March 3, 2020 | XRN | A | 51,950 | · | · | 244,898 Direct | +26.92% | Acquired | (price as of 2026-10-02) |
| March 3, 2020 | XRN | A | 6,415 | · | · | 192,948 Direct | +3.44% | Acquired | (price as of 2026-10-02) |
| March 3, 2020 | XRN | A | 20,199 | · | · | 186,533 Direct | +12.14% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 4,500 | · | · | 166,334 Direct | +2.78% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 9,136 | · | · | 161,834 Direct | +5.98% | Acquired | (price as of 2026-10-02) |
| March 5, 2019 | XRN | A | 18,382 | · | · | 152,698 Direct | +13.69% | Acquired | (price as of 2026-10-02) |
| March 13, 2018 | XRN | P | 2,000 | $7.20 | $14,400 | 28,740 Direct | +7.48% | Acquired | -5.5% (price as of 2026-10-02) |
| March 13, 2018 | XRN | P | 2,000 | $7.06 | $14,120 | 26,740 Direct | +8.08% | Acquired | -3.7% (price as of 2026-10-02) |
| March 12, 2018 | XRN | P | 2,000 | $7.12 | $14,240 | 24,740 Direct | +8.80% | Acquired | -4.5% (price as of 2026-10-02) |
| March 5, 2018 | XRN | A | 13,111 | · | · | 134,316 Direct | +10.82% | Acquired | (price as of 2026-10-02) |
| March 5, 2018 | XRN | A | 9,730 | · | · | 121,205 Direct | +8.73% | Acquired | (price as of 2026-10-02) |
| Nov. 14, 2017 | XRN | P | 2,630 | $9.29 | $24,433 | 22,740 Direct | +13.08% | Acquired | -26.8% (price as of 2026-10-02) |
| Oct. 11, 2017 | XRN | A | 32,787 | · | · | 111,475 Direct | +41.67% | Acquired | (price as of 2026-10-02) |
| June 30, 2017 | XRN | P | 11,100 | $9.00 | $99,900 | 20,110 Direct | +123.20% | Acquired | -24.4% (price as of 2026-10-02) |
| Dec. 21, 2016 | XRN | A | 8,688 | · | · | 78,688 Direct | +12.41% | Acquired | (price as of 2026-10-02) |
| July 1, 2016 | XRN | P | 9,000 | $10.01 | $90,090 | 9,000 Direct | · | Acquired | -32.0% (price as of 2026-10-02) |
| July 1, 2016 | XRN | P | 14,000 | · | · | 70,000 Direct | +25.00% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 26, 2025 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 23,613 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock | · | · | 29,384 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 62,176 | Acquired |
| Feb. 28, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 13,175 | Acquired |
| Feb. 23, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 36,563 | Acquired |
| March 4, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 27,698 | Acquired |
| Feb. 28, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 18,116 | Acquired |
| May 26, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 8,890 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock | · | · | 39,680 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 34,759 | Acquired |
| July 9, 2020 | XRN | LTIP Unit [F1] | Common Stock | · | · | 191,205 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 51,950 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock | · | · | 6,415 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 20,199 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F5] | Common Stock | · | · | 4,500 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 9,136 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 18,382 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock | · | · | 13,111 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock | · | · | 9,730 | Acquired |
| Oct. 11, 2017 | XRN | LTIP Units [F1] | Common Stock | · | · | 32,787 | Acquired |
| Dec. 21, 2016 | XRN | LTIP Unit [F1] | Common Stock | · | · | 8,688 | Acquired |
| July 1, 2016 | XRN | LTIP Unit [F1] | Common Stock | · | · | 14,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $700,000 | · | $1,080,000 | · | $401,100 | · | · | $2,181,100 |
| 2021 | $600,000 | · | $540,000 | · | $366,795 | · | · | $1,506,795 |
| 2018 | · | · | $395,978 | · | · | · | · | $506,646 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.